We have lowered our forecasts following Imint’s Q3 report and management’s comments regarding the Chinese market, resulting in a decreased fair value range. We do believe, however, that the move towards cheaper phones and upsales to existing customers lay ground for double-digit growth over the coming years. We argue that the recent share price decline is excessive, and our updated base case offers upside from current levels.
Read more and download the research update: http://bit.ly/34Cepc0
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye – Research Powered Investment Banking. https://www.redeye.se/about/
